Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators

References

• Ortiz-Flores AE, Luque-Ramírez M, Escobar-Morreale HF. Polycystic ovary syndrome in adult women. Med Clin. 2019;152(11):1–8. doi:10.1016/j.medcli.2018.11.019.
   PubMed Web of Science ®Google Scholar
• Zeng X, Xie YJ, Liu YT, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–221. doi:10.1016/j.cca.2019.11.003.
   PubMed Web of Science ®Google Scholar
• Layegh P, Mousavi Z, Farrokh Tehrani D, et al. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: comparison between obese and non-obese PCOS patients. IJRM. 2016;14(4):263–270. doi:10.29252/ijrm.14.4.263.
   Google Scholar
• Couto Alves A, Valcarcel B, Mäkinen VP, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes. 2017;41(9):1331–1340. doi:10.1038/ijo.2017.126.
   Web of Science ®Google Scholar
• Ejzenberg D, Gomes TJO, Monteleone PAA, et al. Prognostic factors for pregnancy after intrauterine insemination. Int J Gynaecol Obstet. 2019;147(1):65–72. doi:10.1002/ijgo.12898.
   PubMed Web of Science ®Google Scholar
• The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne: international Diabetes Institute, 2000.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004.
   Web of Science ®Google Scholar
• Soonthornpun S, Setasuban W, Thamprasit A, et al. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. 2003;88(3):1019–1023. doi:10.1210/jc.2002-021127.
   PubMed Web of Science ®Google Scholar
• Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83(6):1717–1723. doi:10.1016/j.fertnstert.2005.01.096.
   PubMed Web of Science ®Google Scholar
• Shi W, Zhao Q, Zhao X, et al. Analysis of endocrine and metabolic indexes in non-obese patients with polycystic ovary syndrome and its compare with obese patients. Diabetes Metab Syndr Obes. 2021;14:4275–4281. doi:10.2147/DMSO.S329108.
   PubMed Web of Science ®Google Scholar
• Shirazi FKH, Khodamoradi Z, Jeddi M. Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS). BMC Endocr Disord. 2021;21(1):45. doi:10.1186/s12902-021-00710-z.
   PubMed Web of Science ®Google Scholar
• Wang C, Wen YX, Mai QY. Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome. Exp Ther Med. 2022;23(3):221. doi:10.3892/etm.2022.11145.
   PubMed Web of Science ®Google Scholar
• Wickham EP, 3rd, Cheang KI, Clore JN, et al. Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism. 2011;60(3):366–372. doi:10.1016/j.metabol.2010.02.019.
   PubMed Web of Science ®Google Scholar
• Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(4):E628–E637. doi:10.1210/jc.2012-3908.
   PubMed Web of Science ®Google Scholar
• Bahçeci E, Kaya C, Karakaş S, et al. Serum X-box-binding protein 1 levels in PCOS patients. Gynecol Endocrinol. 2021;37(10):920–924. doi:10.1080/09513590.2021.1942449.
   PubMed Web of Science ®Google Scholar
• De Leo V, Musacchio MC, Cappelli V, et al. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14(1):38. doi:10.1186/s12958-016-0173-x.
   PubMedGoogle Scholar
• Liou TH, Yang JH, Hsieh CH, et al. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960–1965. doi:10.1016/j.fertnstert.2008.09.003.
   PubMed Web of Science ®Google Scholar
• Cengiz H, Ekin M, Dagdeviren H, et al. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;180:46–50. doi:10.1016/j.ejogrb.2014.06.018.
   PubMed Web of Science ®Google Scholar
• Comstock IA, Diaz-Gimeno P, Cabanillas S, et al. Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis. Fertil Steril. 2017;107(3):740–748.e2. doi:10.1016/j.fertnstert.2016.11.009.
   PubMed Web of Science ®Google Scholar
• Bonilla-Musoles F, Raga F, Osborne NG, et al. Endometrial receptivity: evaluation with ultrasound. Ultrasound Q. 2013;29(1):3–20. doi:10.1097/RUQ.0b013e318281b60a.
   PubMed Web of Science ®Google Scholar
• Nishihara S, Fukuda J, Ezoe K, et al. Does the endometrial thickness on the day of the trigger affect the pregnancy outcomes after fresh cleaved embryo transfer in the clomiphene citrate-based minimal stimulation cycle? Reprod Med Biol. 2020;19(2):151–157. doi:10.1002/rmb2.12315.
   PubMed Web of Science ®Google Scholar
• Elci E, Kaya C, Cim N, et al. Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries. Gynecol Endocrinol. 2017;33(1):43–47. doi:10.1080/09513590.2016.1203893.
   PubMed Web of Science ®Google Scholar
• Guney G, Taskin MI, Baykan O, et al. Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study. Ther Adv Endocrinol Metab. 2021;12:20420188211049607. doi:10.1177/20420188211049607.
   Web of Science ®Google Scholar
• Lam P, Johnson I, Raine-Fenning N. Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic. Ultrasound Obstet Gynecol. 2009;34(3):326–334. doi:10.1002/uog.7314.
   PubMed Web of Science ®Google Scholar
• Chen X, He J, Ding Y, et al. The role of MTOR in mouse uterus during embryo implantation. Reproduction. 2009;138(2):351–356. doi:10.1530/REP-09-0090.
   PubMed Web of Science ®Google Scholar
• Gonzalez D, Thackeray H, Lewis PD, et al. Loss of WT1 expression in the endometrium of infertile PCOS patients: a hyperandrogenic effect? J Clin Endocrinol Metab. 2012;97(3):957–966. doi:10.1210/jc.2011-2366.
   PubMed Web of Science ®Google Scholar
• Younas K, Quintela M, Thomas S, et al. Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11. J Mol Med (Berl). 2019;97(9):1315–1327. doi:10.1007/s00109-019-01809-6.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi:10.1016/j.metabol.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Oróstica L, García P, Vera C, et al. Effect of TNF-α on molecules related to the insulin action in endometrial cells exposed to hyperandrogenic and hyperinsulinic conditions characteristics of polycystic ovary syndrome. Reprod Sci. 2018;25(7):1000–1009. doi:10.1177/1933719117732157.
   PubMed Web of Science ®Google Scholar
• Zhai J, Liu CX, Tian ZR, et al. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod. 2012;87(2):29. doi:10.1095/biolreprod.112.099788.
   PubMed Web of Science ®Google Scholar
• Mozzanega B, Mioni R, Granzotto M, et al. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci. 2004;1034(1):364–374. doi:10.1196/annals.1335.038.
   PubMedGoogle Scholar
• Chang EM, Han JE, Seok HH, et al. Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation-in vitro fertilization-embryo transfer cycle. Clin Endocrinol. 2013;79(1):93–99. doi:10.1111/cen.12099.
   PubMed Web of Science ®Google Scholar
• Sharawy MH, El-Awady MS, Megahed N, et al. Attenuation of insulin resistance in rats by agmatine: role of SREBP-1c, mTOR and GLUT-2. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(1):45–56. doi:10.1007/s00210-015-1174-6.
   PubMed Web of Science ®Google Scholar
• Li R, Wu J, He J, et al. Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia. Mol Med Rep. 2017;15(5):2503–2510. doi:10.3892/mmr.2017.6322.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie X, Zhu W. Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications. J Huazhong Univ Sci Technolog Med Sci. 2010;30(5):638–642. doi:10.1007/s11596-010-0556-8.
   PubMedGoogle Scholar
• Riley JK, Jungheim ES. Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? Fertil Steril. 2016;106(3):520–527. doi:10.1016/j.fertnstert.2016.07.1069.
   PubMed Web of Science ®Google Scholar
• Motta AB. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des. 2012;18(17):2482–2491. doi:10.2174/13816128112092482.
   PubMed Web of Science ®Google Scholar
• Liao Y, Huang R, Sun Y, et al. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients. Reprod Biol Endocrinol. 2017;15(1):9. doi:10.1186/s12958-017-0227-8.
   PubMedGoogle Scholar